Financhill
Back

Immuneering Quote, Financials, Valuation and Earnings

Sell
48

IMRX
Immuneering

Last Price:
1.54
Seasonality Move:
24.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Immuneering Price Quote

$1.54

Immuneering Key Stats

Sell
48
Immuneering (IMRX) is a Sell

Day range:
$1.50 - $1.64
52-week range:
$1.38 - $11.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
141.59
P/B ratio:
0.58%

Volume:
122.7K
Avg. volume:
429.5K
1-year change:
-81.69%
Market cap:
$45.7M
Revenue:
$0
EPS:
$-1.87

How Much Does Immuneering Make?

Data Unavailable

Is Immuneering Growing As A Company?

Data Unavailable

Immuneering Stock Price Performance

  • Did Immuneering Stock Go Up Last Month?
    Immuneering share price went down by -16.3% last month
  • Did IMRX's Share Price Rise Over The Last Year?
    IMRX share price fell by -81.69% over the past 1 year

What Is Immuneering 52-Week High & Low?

  • What Is Immuneering’s 52-Week High Share Price?
    Immuneering has traded as high as $11.92 over the past 52 weeks
  • What Is Immuneering’s 52-Week Low Share Price?
    Immuneering has traded as low as $1.38 over the past 52 weeks

Immuneering Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Immuneering?

  • How Much Debt Does Immuneering Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Immuneering Have?
    Cash and short term investments quarterly total is $71.3M
  • What Is Immuneering’s Book Value Per Share?
    Book value per share is 2.65

Is Immuneering Cash Flow Positive?

  • What Is IMRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$50M
  • What Is Immuneering’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $29.2M
  • What Is Immuneering’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $9.7M

Immuneering Return On Invested Capital

Data Unavailable

Immuneering Earnings Date & Stock Price

  • What Is Immuneering's Stock Price Today?
    A single share of IMRX can be purchased today for 1.54
  • What Is Immuneering’s Stock Symbol?
    Immuneering trades on the nasdaq under the ticker symbol: IMRX
  • When Is Immuneering’s Next Earnings Date?
    The next quarterly earnings date for Immuneering is scheduled on August 2, 2024
  • When Is IMRX's next ex-dividend date?
    Immuneering's next ex-dividend date is May 17, 2024
  • How To Buy Immuneering Stock?
    You can buy Immuneering shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Immuneering Competitors

  • Who Are Immuneering's Competitors?
    Below is a list of companies who compete with Immuneering or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Elicio Therapeutics Inc (ELTX)
    • Geron Corp (GERN)
    • SELLAS Life Sciences Group Inc (SLS)
    • Vistagen Therapeutics Inc (VTGN)

Immuneering Dividend Yield

Data Unavailable

Immuneering Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.56%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 15.14
Upside from Last Price: 883.3%

Major Shareholders

  • How many IMRX shares are owned by institutional investors?
    25.8M IMRX shares are owned by institutional investors
  • How many IMRX shares are owned by insiders?
    4M IMRX shares are owned by insiders